Data / Form D filings / TruTag Technologies, Inc.
TruTag Technologies, Inc.: Form D filings
TruTag Technologies, Inc., a pharmaceuticals company in Emeryville, CA, filed 5 Form D notices with the SEC between 2012 and 2021. The latest, on November 24, 2021, reports $14.7 million sold of a $24.2 million offering to 12 investors.
Find out what TruTag Technologies, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2200 POWELL STREET #1035, Emeryville, CA, 94608
- Phone
- (510) 879-6408
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1560969
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 24, 2021 | New notice | $24,242,588 | $14,692,572 | $9,550,016 | 12 | Nov 12, 2021 | sec.gov |
| Sep 3, 2019 | New notice | $43,055,938 | $25,471,113 | $17,584,825 | 30 | Aug 22, 2019 | sec.gov |
| Jun 13, 2014 | Amendment | $17,413,518 | $16,776,527 | $636,991 | 53 | Oct 11, 2012 | sec.gov |
| Oct 26, 2012 | Amendment | $12,762,030 | $9,276,568 | $3,485,462 | 52 | Oct 11, 2012 | sec.gov |
| Oct 25, 2012 | New notice | $12,275,039 | $9,276,568 | $2,998,471 | 52 | Oct 11, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michael O'Neill, Ph.D. | Executive Officer | |
| Sean M. O. Karamchandani | Director | |
| Jennifer M. O. McFarlane | Director | |
| Leslie Leff | Director | |
| Matthew M. O. Cohen | Director | |
| Peter M. O. Wong | Executive Officer | |
| Gregory M. O. Leong | Director | |
| Michael Bartholomeusz | Executive Officer, Director | |
| Albert M. O. Pleus | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Nov 22, 2021 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what TruTag Technologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.